Danish pharmaceutical company punished on the stock exchange after weight loss data
Zealand Pharma's stock plummets nearly 30% following the release of disappointing weight loss trial results for its drug Petrilintid.
A compact global news feed for the bigger picture.
Zealand Pharma's stock plummets nearly 30% following the release of disappointing weight loss trial results for its drug Petrilintid.
Loading Intelligence...
Select a report from the feed to view analysis and related coverage.
A compact global news feed for the bigger picture. It pulls reporting from outlets around the world so you can compare what gets covered, what gets missed, and how it’s framed.
It can feel dense at first (on purpose): more signal, less fluff. No ads. No trackers. No agenda.